Advertisement
Advertisement
U.S. markets close in 3 hours 39 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Sangamo Therapeutics, Inc. (SGMO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.9650+0.1950 (+5.17%)
As of 12:21PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close3.7700
Open3.7700
Bid3.9600 x 1000
Ask3.9700 x 900
Day's Range3.7700 - 4.0475
52 Week Range3.4800 - 12.8300
Volume745,933
Avg. Volume1,327,786
Market Cap602.601M
Beta (5Y Monthly)1.50
PE Ratio (TTM)N/A
EPS (TTM)-1.2330
Earnings DateAug 03, 2022 - Aug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est16.04
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SGMO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Sangamo Therapeutics, Inc.
    Analyst Report: Merck & Co IncMerck & Co. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading vaccine business and an animal health division. MRK shares are included in the S&P 500.
    Rating
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
Advertisement
Advertisement